NTM486-04, NTM174-04,

Similar documents
Data Sheet. Application Monitor glucocorticoid signaling pathway activity. Screen activators or inhibitors of the glucocorticoid signaling pathway.

Plasmid DNA transfection of LN-229 human glioblastoma cells with the Biontex K2 Transfection System

Plasmid DNA transfection of SW480 human colorectal cancer cells with the Biontex K2 Transfection System

IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity

Data Sheet. Glucocorticoid Receptor Pathway GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: w70666

Data Sheet. Glucocorticoid Receptor Pathway GR-GAL4 Reporter (Luc)-HEK293 cell Line Catalog #: 60655

Data Sheet. SBE Reporter Kit (TGFβ/SMAD signaling pathway) Catalog #: 60654

Supplementary Information Temperature-responsive Gene Silencing by a Smart Polymer

Supplemental Online Material. The mouse embryonic fibroblast cell line #10 derived from β-arrestin1 -/- -β-arrestin2 -/-

TransIT-TKO Transfection Reagent

pdsipher and pdsipher -GFP shrna Vector User s Guide

The Transfection Collection TCF/LEF Transient Pack Wnt / -catenin Signaling Pathway Catalog #: 79273

Cignal Reporter Assay Handbook

Data Sheet PD-1 / NFAT - Reporter - Jurkat Recombinant Cell Line Catalog #: 60535

Data Sheet. CRE/CREB Reporter Assay Kit (camp/pka Cell Signaling Pathway) Catalog #: 60611

TransIT-X2 Dynamic Delivery System

Data Sheet. TCF/LEF Reporter Kit Wnt / -catenin signaling pathway Catalog #: 60500

TransIT-TKO Transfection Reagent

Apoptosis And Anti-tumor Effect Induced By Mtor Inhibitor And Autophagy Inhibitor In Human Osteosarcoma Cells

CRE/CREB Reporter Assay Kit camp/pka Cell Signaling Pathway Catalog #: 60611

Transfection of CRISPR/Cas9 Nuclease NLS ribonucleoprotein (RNP) into adherent mammalian cells using Lipofectamine RNAiMAX

TransIT -LT1 Transfection Reagent

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536

Data Sheet GITR / NF-ĸB-Luciferase Reporter (Luc) - Jurkat Cell Line Catalog #60546

Transfection of Jurkat cells with METAFECTENE

TransIT -Keratinocyte Transfection Reagent

TransIT Transfection Reagent

CONCERNING HUMAN CANCER CELL LINES

Supplementary Figure 1, related to Figure 1. GAS5 is highly expressed in the cytoplasm of hescs, and positively correlates with pluripotency.

Product: Arrest-In TM Transfection Reagent for RNAi

Supplementary Table 1. Sequences for BTG2 and BRCA1 sirnas.

Nature Medicine: doi: /nm.2171

TransIT -LT1 Transfection Reagent

sirna Transfection Reagent

TransIT Transfection Reagent

TransIT -Insect Transfection Reagent

TransIT -CHO Transfection Kit

Supplementary data. sienigma. F-Enigma F-EnigmaSM. a-p53

M X 500 µl. M X 1000 µl

Alpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by

TransIT -BrCa Transfection Reagent

8Br-cAMP was purchased from Sigma (St. Louis, MO). Silencer Negative Control sirna #1 and

Supplemental Fig. 1: PEA-15 knockdown efficiency assessed by immunohistochemistry and qpcr

Supplemental Methods Cell lines and culture

used at a final concentration of 5 ng/ml. Rabbit anti-bim and mouse anti-mkp2 antibodies were

jetpei -Macrophage in vitro DNA transfection reagent PROTOCOL

Convoy TM Transfection Reagent

TransIT -Lenti Transfection Reagent

TransIT -Keratinocyte Transfection Reagent

Arrest-In Transfection Reagent Catalog numbers: ATR1740, ATR1741, ATR1742, ATR1743

TransIT -BrCa Transfection Reagent

PromoFectin-HUVEC Cell Transfection Reagent. Instruction Manual. Cat.No. PK-CT-2000-HUV-10 PK-CT-2000-HUV-50

TransIT -CHO Transfection Kit

TransIT -CHO Transfection Kit

Assay ID Assay name Description Components of the assay SYS-A115 DRD5/ARRB2 targetscreener

TransIT -293 Transfection Reagent

TransIT -Insect Transfection Reagent

Protocol for induction of expression and cell lysate production

TransIT-PRO Transfection Reagent Protocol for MIR 5740 and 5750

TransIT-PRO Transfection Kit Protocol for MIR 5700 and 5760

Transfection Kit Protocol for MIR 2900, 2904, 2905, 2906

Supplementary Material

T1: Pure spongia-13(16),14-dien-19-oic acid (T1) (514 mg) was obtained from a Spongia sp.

TransIT -293 Transfection Reagent

Supplementary Protocol. sirna transfection methodology and performance

RiboCellin sirna Delivery Reagent Protocol vs1 2/12

Instructions. Torpedo sirna. Additional Material Required. Overview. Important Guidelines. Specifications. Shipping and Storage.

jetprime DNA & sirna transfection reagent

Table 1. Primers, annealing temperatures, and product sizes for PCR amplification.

Amaxa Cell Line Nucleofector Kit L

TransIT -Prostate Transfection Kit

High throughput screening: Huh-7 cells were seeded into 96-well plate (2000

Establishment of Evaluation Method for sirna Delivery Using Stable Cell Line Carrying the Luciferase Reporter Gene

Assay ID Assay name Description Components of the assay SYS-A044 ERBB2-3/ SH2(GRB2) receptor. readout

Document S1. Supplemental Experimental Procedures and Three Figures (see next page)

PromoFectin-Hepatocyte Cell Transfection Reagent. Instruction Manual. Cat.No. PK-CT-2000-HEP-10 PK-CT-2000-HEP-50

Supplementary Information. A novel human endogenous retroviral protein inhibits cell-cell fusion. Supplementary Figures:

CalPhos Mammalian Transfection Kit User Manual

Supplemental Information

Lullaby sirna Transfection Reagent - Results

Comparative Analysis of Argonaute-Dependent Small RNA Pathways in Drosophila

jetprime in vitro DNA & sirna transfection reagent PROTOCOL

RNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by. 5 AGACACAAACACCAUUGUCACACUCCACAGC; Rand-2 OMe,

Avalanche -Omni Transfection Reagent

HeLa cells stably transfected with an empty pcdna3 vector (HeLa Neo) or with a plasmid

The highly efficient Transfection Reagent for Mammalian Cells. For ordering information, SDS, publications and application notes see

TransIT -Jurkat Transfection Reagent

Transfection of Mouse ES Cells and Mouse ips cells using the Stemfect 2.0 -mesc Transfection Reagent

Figure S2. Response of mouse ES cells to GSK3 inhibition. Mentioned in discussion

Validation & Assay Performance Summary

Avalanche -Omni Transfection Reagent

SUPPLEMENTAL MATERIALS SIRTUIN 1 PROMOTES HYPEROXIA-INDUCED LUNG EPITHELIAL DEATH INDEPENDENT OF NRF2 ACTIVATION

Data Sheet. Hedgehog Signaling Pathway Gli Reporter NIH3T3 Cell Line Catalog #: 60409

Supporting Online Material for

Contents Introduction 2. Storage and Stability.. 2. Kit Contents Important Notes sirna Transfection Protocols 3

Part Number: GY-SMPE010. Smart PEI. Instructions for Use. For research use only. Not for use in humans.

Avalanche -Everyday Transfection Reagent

Ingenio Electroporation Kits and Solution

3D Transfection System

Transfection Reagent SPECIFICATIONS MATERIALS. For Research Use Only. Materials Supplied. Materials required, but not supplied

Transcription:

Transfection of transformed human trabecular meshwork TM5, and primary human NTM210-05, NTM486-04, NTM174-04, and NTM153-00 cells with Metafectene Easy Adnan Dibas1A,C, Ming Jiang1A,C, Thomas Yorio1A,C. A Pharmacol & Neuroscience BCell Biology and Anatomy CNorth Texas Eye Research Institute 1UNT Health Science Center Fort Worth TX Glucocorticoids (GCs), a family of steroids, exert their effects through their interaction with glucocorticoid receptors (GR). Human GR exists in two forms, GRα and GRβ. GRα is known to bind to GCs and regulate expression of thousands of genes. However, GRß which does not bind GC, has been reported to suppress GRα activity, and implicated in several glucocorticoid resistance diseases including asthma, arthritis, and inflammatory bowel disease. Moreover, GRβ also appears to play a critical role in regulating glucocorticoid responsiveness in the trabecular meshwork (TM) cells by affecting the transcriptional activity of the GRα response. Therefore, knock-down of GRß may be of therapeutic uses. In the current report, metafectene was used to transfect primary and transformed human trabecular meshwork cells with sirnas of GRβ receptor. 1 Materials and methods 1.1 Materials Metafectene Easy was a gift and subsequently purchased from Biontex Laboratories GmbH (Munich, Germany), Lipofectamine TM 2000 was purchased from Invitrogen Inc. (Carlsbad, CA). Dexamethasone (DEX) was obtained from Sigma-Aldrich Corp (St. Louis, MO). Polyclonal anti-grβ and polyclonal antibodies were purchased from Affinity Bioreagents (Golden, CO). psirnahh1gfpzeo (empty vector) was purchased from InvivoGen (San Diego, CA). GR β-sirna#1: 5 CATGAAAATGTTATGTGGTTT 3, GR β-sirna#3: 5 TTTCCGAGTTCTTGTTTCAGG 3, GR β-sirna#4: 5 AACCAGAAAGCACATCTCACA 3, and Non-targeting #1: Cat.#: D001206-13-05 were custom-made by Eurogenetec Inc. (San Diego, CA). pgre-luc plasmid was obtained from BD Clontech (Palo Alto, CA).

1.2 Cells The human transformed NTM-5, and primary NTM210-05, NTM486-04, NTM174-04, and NTM153-00 trabecular meshwork cells were obtained from Alcon Ltd (Fort Worth, TX). The cells were cultured in 37 C and 5% CO2 in Dulbecco s modified Eagle s medium (DMEM) supplemented with 10% fetal bovine serum, penicillin and streptomycin, and glutamate (Invitrogen, Grand Island, NY). Confluent cells were used in most studies as described (1-3). 2 Plasmid and Transfections 2.1 Transfection of GRβ sirna When cells were approximately 70-80% confluent, they were transfected with plasmids that once inside the cell produce; scrambled sirna, GRb-siRNA#1, GRb-siRNA#3, and GRb-siRNA#4. Oligo DNA sequences that will produce; sirnas #1, 3, 4, were inserted into the empty vector (psirnahh1gfpzeo) and subsequently used for transfection experiments designed for luciferase assay. A stock of plasmid DNA and Metafectene Easy was prepared where 10 µg of plasmid DNA was mixed with 10 µl of Metafectene Easy (1:1). 2.2 Luciferase Assay Luciferase assay was used to determine the glucocorticoid responsiveness after transient knockdown of GR using GR -sirna#1,3, & 4 in TM5 and four primary TM cell lines; NTM210-05, NTM486-04, NTM174-04, and NTM153-00. Cells (1 x 10 5 ) were seeded in 12-well-plates for 24 hours in 1ml of DMEM media. TM cells 70-80% confluent were transfected with 800ng/well of plasmid DNA (empty vector or sirna), 400ng/well of a mercury luciferase reporter pgre-luc (BD Clontech, Palo Alto, CA), and also co-transfected with 50ng/well of psv40-β -Galactosidase as a control for 10 hours in serumfree and antibody-free DMEM. The cells were washed with serum-free DMEM two times and were treated for 24 hours with vehicle (Ethanol) or DEX (dexamethasone, 100nM/well, dissolved in ethanol) (Sigma Chemical, St Louis, MO) in serum-free DMEM. Whole cell lysates were prepared and luciferase activity performed with a luminometer. This activity was normalized with the reading of psv40-β-galactosidase (Promega, Madison, Wisconsin, USA) which served as a control for normalizing the transfection efficiency of the plasmid into the cells. Data were plotted as a fold change from each basal activity of control vehicle treatment and represent the mean±se of results in two independent experiments repeated 2-4 times per experiment. 2.3 sirna transfection for western blot TM cells 70-80% confluent were transfected with 10 g of scrambled sirna, GR -sirna#1, GR sirna#3, and GR -sirna#4 for 10 hours, respectively in NTM5 cell line in serum-free and antibioticfree DMEM in 100mm dish. The media was changed to complete medium for 72 hours and GRβ was immunoprecipiated and immunoblot analysis was performed.

3 Results and discussion Fig. 1. Metafectene Easy which has at least twice the transfection efficiency as Lipofactamine 2000. Ten microgram of empty vector-gfp (psirna-hh1gfpzeo, InvivoGenCA) was mixed with equal volume of metafectene or Lipofactamine 2000 (1:1 ratio) in DMEM-serum free media. As shown, Metafectene Easy produced ~ 70% fluorescent cells (B) vs. ~ 30% fluorescent cells in Lipofactamine transfected cells (A). No toxicities were observed in using Metafectene Easy.

Figure 2. Luciferase assay was used to determine the glucocorticoid responsiveness after transient knockdown of GRβ in TM cell lines (NTM-5, primary NTM210-05, NTM486-04, NTM174-04, and NTM153-00). In 12-well-plates, 100,000 cells were seeded for 24 hours. NTM5 cells were transfected with 800ng/well of empty vector and three sirna structures, 400ng/well of a mercury luciferase reporter pgre-luc (BD Clontech, Palo Alto, CA), and also co-transfected with 50ng/well of psv40-β-galactosidase as a control for 10 hours. The cells were washed with serum-free DMEM two times. The cells were treated for 24 hours with vehicle (Ethanol) or DEX (Dexamethasone, 100nM/well, dissolved in ethanol) (Sigma Chemical, St Louis, MO) in serumfree DMEM. Whole cell lysates were prepared and luciferase activity performed with a luminometer. This activity was normalized with the reading of psv40-β-galactosidase (Promega, Madison, Wisconsin, USA) which serves as a control for normalizing the transfection efficiency of the plasmid into cells. Data were plotted as fold change from each basal activity of control vehicle treatment and represent the mean±se of results in two independent experiments repeated 2-6 times per experiment. Figure 3. Western blot analysis after transient knockdown of GRβ in TM5 cell line. In a 100-mm dish, 200,000 cells were seeded for 24 hours. Twelve microliters of sirna stock (10 µm) were mixed with 588 µl of serum-free DMEM media. In a separate tube, 12 µl of Metafectene Easy were mixed with 588 µl of serum-free DMEM media. After 5 minutes, Metafectene Easy mixture was added to sirna mixture and mixture was allowed to sit for 20 minutes at room temperature. At the end of 20 minutes, 5 ml of serum-free media was added (6 ml final volume) and the entire mixture was added to dish (final concentration of sirna is 20 nm). The cells were incubated for 24 hours then 6 ml of DMEM media containing 10% FBS and antibiotics were added. After 72-96 hours, GRβ was immunoprecipiated using rabbit anti-grβ and samples were run on a 7.5% SDS-PAGE followed by western blot. As shown, all 3 sirnas significantly decreased GRβ protein levels.

4 Conclusion / summary: Metafectene Easy was highly effective in transfecting both transformed as well as primary human trabecular meshwork cells without noticeable toxicities. 5 References: 1. Pang IH. Shade DL, Clark AF, Steely HT, DeSantis L. Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr. Eye Res. 13:51-63, 1994 2. Steely HT, Browder SH, Julian MB, Miggans ST, Wilson KL, Clark AF. The effect of dexamethasone on fibronectin expression in cultured trabecular meshwork cells. IVOS. 33:2242-2250, 1992. 3. Zhang X, Ognibene CM, Clark AF, Yorio T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta. Exp Eye Res. 84(2):275-284, 2007.